These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 31602204)
1. Smoking alters the evolutionary trajectory of non-small cell lung cancer. Yu XJ; Chen G; Yang J; Yu GC; Zhu PF; Jiang ZK; Feng K; Lu Y; Bao B; Zhong FM Exp Ther Med; 2019 Nov; 18(5):3315-3324. PubMed ID: 31602204 [TBL] [Abstract][Full Text] [Related]
2. Common cancer-driver mutations and their association with abnormally methylated genes in lung adenocarcinoma from never-smokers. Tessema M; Rossi MR; Picchi MA; Yingling CM; Lin Y; Ramalingam SS; Belinsky SA Lung Cancer; 2018 Sep; 123():99-106. PubMed ID: 30089603 [TBL] [Abstract][Full Text] [Related]
3. Promoter methylation of RASSF1A and DAPK and mutations of K-ras, p53, and EGFR in lung tumors from smokers and never-smokers. Liu Y; Gao W; Siegfried JM; Weissfeld JL; Luketich JD; Keohavong P BMC Cancer; 2007 May; 7():74. PubMed ID: 17477876 [TBL] [Abstract][Full Text] [Related]
4. Divergent epidermal growth factor receptor mutation patterns between smokers and non-smokers with lung adenocarcinoma. Tseng JS; Wang CL; Yang TY; Chen CY; Yang CT; Chen KC; Hsu KH; Tsai CR; Chang GC Lung Cancer; 2015 Dec; 90(3):472-6. PubMed ID: 26474957 [TBL] [Abstract][Full Text] [Related]
5. Higher TP53 somatic mutation prevalence from liquid biopsy analysis in ever smoker non-small-cell lung cancer patients. Erdem HB; Alay MT; Özdemir Z; Çevik E; Ateş Ö; Karaçin C; Şahin İ; Doğan M; Bahsi T Mutat Res; 2024; 828():111847. PubMed ID: 38071953 [TBL] [Abstract][Full Text] [Related]
6. Identification of enriched driver gene alterations in subgroups of non-small cell lung cancer patients based on histology and smoking status. An SJ; Chen ZH; Su J; Zhang XC; Zhong WZ; Yang JJ; Zhou Q; Yang XN; Huang L; Guan JL; Nie Q; Yan HH; Mok TS; Wu YL PLoS One; 2012; 7(6):e40109. PubMed ID: 22768234 [TBL] [Abstract][Full Text] [Related]
7. Effect of smoking status on progression-free and overall survival in non-small cell lung cancer patients receiving erlotinib or gefitinib: a meta-analysis. Sohn HS; Kwon JW; Shin S; Kim HS; Kim H J Clin Pharm Ther; 2015 Dec; 40(6):661-71. PubMed ID: 26573867 [TBL] [Abstract][Full Text] [Related]
8. [Driver genes expression and clinical characteristics of targeted therapy in non-small cell lung cancer in Yunnan-Kweichow Plateau]. Lin YP; Li Q; Ma LY; Liu X; Dai M; Wang XX; Li HS; Liu JX; Shen ZH; Guo YJ; Du YX; Yang RJ; Huang YC; Zhou YC Zhonghua Zhong Liu Za Zhi; 2020 Sep; 42(9):735-740. PubMed ID: 32988155 [No Abstract] [Full Text] [Related]
9. Family history of lung cancer in never smokers with non-small-cell lung cancer and its association with tumors harboring EGFR mutations. Gaughan EM; Cryer SK; Yeap BY; Jackman DM; Costa DB Lung Cancer; 2013 Mar; 79(3):193-7. PubMed ID: 23273562 [TBL] [Abstract][Full Text] [Related]
10. Investigation of EGFR and ALK mutation frequency and treatment results in advanced non-small cell lung cancer. Komurcuoglu B; Karakurt G; Kaya OO; Diniz G; Kırbıyık O; Evkan A; Yalnız E J Cancer Res Ther; 2023 Apr; 19(Supplement):S183-S190. PubMed ID: 37147996 [TBL] [Abstract][Full Text] [Related]
11. Current status of research and treatment for non-small cell lung cancer in never-smoking females. Saito S; Espinoza-Mercado F; Liu H; Sata N; Cui X; Soukiasian HJ Cancer Biol Ther; 2017 Jun; 18(6):359-368. PubMed ID: 28494184 [TBL] [Abstract][Full Text] [Related]
12. The role of smoking status on the progression-free survival of non-small cell lung cancer patients harboring activating epidermal growth factor receptor (EGFR) mutations receiving first-line EGFR tyrosine kinase inhibitor versus platinum doublet chemotherapy: a meta-analysis of prospective randomized trials. Hasegawa Y; Ando M; Maemondo M; Yamamoto S; Isa S; Saka H; Kubo A; Kawaguchi T; Takada M; Rosell R; Kurata T; Ou SH Oncologist; 2015 Mar; 20(3):307-15. PubMed ID: 25657199 [TBL] [Abstract][Full Text] [Related]
13. EGFR mutations in patients with lung adenocarcinoma in southwest China: are G719S/A and L861Q more likely detected in tumors derived from smokers? Wang Q; Mou J; Yang X; He Y; Li Z; Luo Q; Li Y; Lin L; Ma Y; Xiao H Lung Cancer (Auckl); 2013; 4():27-33. PubMed ID: 28210132 [TBL] [Abstract][Full Text] [Related]
14. Association between cigarette smoking history, metabolic phenotypes, and Zhang X; Guo X; Gao Q; Zhang J; Zheng J; Zhao G; Okuda K; Tartarone A; Jiang M J Thorac Dis; 2023 Oct; 15(10):5689-5699. PubMed ID: 37969305 [TBL] [Abstract][Full Text] [Related]
15. Dominance of EGFR and insignificant KRAS mutations in prediction of tyrosine-kinase therapy for NSCLC patients stratified by tumor subtype and smoking status. Pesek M; Benesova L; Belsanova B; Mukensnabl P; Bruha F; Minarik M Anticancer Res; 2009 Jul; 29(7):2767-73. PubMed ID: 19596959 [TBL] [Abstract][Full Text] [Related]
17. Association of smoking status with non-small cell lung cancer patients harboring uncommon epidermal growth factor receptor mutation. Ko HW; Shie SS; Wang CW; Chiu CT; Wang CL; Yang TY; Chou SC; Liu CY; Kuo CS; Lin YC; Li LF; Yang CT; Wang CC Front Immunol; 2022; 13():1011092. PubMed ID: 36341427 [TBL] [Abstract][Full Text] [Related]
18. Real World Characterization of Advanced Non-Small Cell Lung Cancer in Never Smokers by Actionable Mutation Status. Kerrigan K; Wang X; Haaland B; Adamson B; Patel S; Puri S; Akerley W Clin Lung Cancer; 2021 Jul; 22(4):260-267.e2. PubMed ID: 33678584 [TBL] [Abstract][Full Text] [Related]
19. Common driver mutations and programmed death-ligand 1 expression in advanced non-small cell lung cancer in smokers and never smokers. Liam CK; Yew CY; Pang YK; Wong CK; Poh ME; Tan JL; Soo CI; Loh TC; Chin KK; Munusamy V; Liam YS; Ibrahim NH BMC Cancer; 2023 Jul; 23(1):659. PubMed ID: 37452277 [TBL] [Abstract][Full Text] [Related]
20. Proportion and clinical features of never-smokers with non-small cell lung cancer. Cho J; Choi SM; Lee J; Lee CH; Lee SM; Kim DW; Yim JJ; Kim YT; Yoo CG; Kim YW; Han SK; Park YS Chin J Cancer; 2017 Feb; 36(1):20. PubMed ID: 28179026 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]